Cancer and IgE

1. Introduction
Erika Jensen-Jarolim, Manuel L. Penichet

2. The Biology of IgE: Molecular Mechanism Restraining Potentially Dangerous High Serum IgE Titres In Vivo
Gernot Achatz, Gertrude Achatz-Straussberger, Stefan Feichtner, Sebastian Koenigsberger, Stefan Lenz, Doris Peckl-Schmid, Nadja Zaborsky, Marinus Lamers

3. The Biology of IgE: The Generation of High-Affinity IgE Antibodies
Maria A. Curotto de Lafaille, Juan J. Lafaille

4. Epidemiological Evidence: IgE, Atopy, and Solid Tumors
Michelle C. Turner

5. Epidemiological Evidence: IgE, Allergies, and Hematopoietic Malignancies
Otoniel Martínez-Maza, Alan Duane Moreno, Wendy Cozen

6. Mast Cells in Allergy and Tumor Disease
Anna Wasiuk, Victor C. Vries, Elizabeth C. Nowak, Randolph J. Noelle

7. The IgE Antibody and Its Use in Cancer Immunotherapy
Tracy R. Daniels, José A. Rodríguez, Elizabeth Ortiz-Sánchez, Gustavo Helguera, Manuel L. Penichet

8. IgE Interacts with Potent Effector Cells Against Tumors: ADCC and ADCP
Sophia N. Karagiannis, Frank O. Nestle, Hannah J. Gould

9. IgE as Adjuvant in Tumor Vaccination
Elisa A. Nigro, Antonio G. Siccardi, Luca Vangelista

10. The Targets of IgE: Allergen-Associated and Tumor-Associated Molecular Patterns
Erika Jensen-Jarolim, Diana Mechtcheriakova, Isabella Pali-Schoell

11. The Role of Th2-Mediated Anti-Tumor Immunity in Tumor Surveillance and Clearance
Ljubov Simson, Julia I. Ellyard, Christopher R. Parish

Nyckelord: Biomedicine, Cancer Research, Immunology, Oncology